¸¶ÀÌÅ©·Î RNA ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Á¦Ç°¡¤¼­ºñ½ºº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
MicroRNA Market Size, Share & Trends Analysis Report By Products & Services (Instruments, Consumables), By Application (Cancer, Infectious Diseases) By End-use, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1405834
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,311,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,708,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,502,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸¶ÀÌÅ©·Î RNA ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ ¸¶ÀÌÅ©·Î RNA ½ÃÀå ±Ô¸ð´Â 2024-2030³â 12.87%ÀÇ CAGRÀ» ±â·ÏÇϸç, 2030³â±îÁö´Â 36¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå °³Ã´Àº ÀÓ»ó½ÃÇè¿¡¼­ ¸¶ÀÌÅ©·Î RNAÀÇ ¼º°øÀûÀÎ ÅëÇÕ°ú ÇÔ²² »õ·Î¿î Áø´Ü Å×½ºÆ® ¹× Ä¡·áÁ¦ °³¹ßÀ» À§ÇÑ ¿¬±¸°³¹ß ±¸»ó¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÇöÀç »ý¸í°øÇÐ »ê¾÷¿¡¼­ ¹ÙÀÌ¿À ÀǾàǰ ºÎ¹®Àº Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. »ý¸í°øÇÐ »ê¾÷¿¡¼­ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÁöÃâÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀϺΠ¹ÙÀÌ¿À Á¦¾à ȸ»ç´Â RNA ±â¹Ý Ä¡·áÁ¦(miRNA ¹× siRNA) °³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷À¸·Î´Â Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, Mirna Therapeutics µîÀÌ ÀÖ½À´Ï´Ù.

»õ·Î¿î Áø´Ü °Ë»ç ¹× Ä¡·áÁ¦ °³¹ßÀ» À§ÇÑ miRNA ¿¬±¸°³¹ß¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áõ°¡¿Í ´õºÒ¾î, ´ë±Ô¸ð ÅõÀÚ°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ç¥ÀûÄ¡·áÁ¦ °³¹ß ¹× ½Å¾à Ÿ±ê ¹ß±¼À» À§ÇÑ Çõ½ÅÀûÀÎ Á¢±Ù¹ýÀ¸·Î ½ÃÀå¿¡ ÁøÀÔÇÑ ½Å±Ô ¾÷üµéµµ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 4¿ù ¿¤½ººñ¾î(Elsevier)¿¡ °ÔÀçµÈ ³í¹®¿¡¼­´Â ¿¬±¸ÆÀÀÌ Áúº´ÀÇ Á¶±â Áø´ÜÀ» À§ÇÑ ¼øÈ¯ miRNAÀÇ ÀÓ»óÀû °¡Ä¡¸¦ º¸¿©ÁÖ´Â ÇöÀç ´ë±Ô¸ð ÄÚȣƮ ¿¬±¸¿¡ ´ëÇÑ °³¿ä¸¦ Á¦°øÇÕ´Ï´Ù.

ƯÈ÷ ÈäºÎ¾Ï°ú °°Àº ¾Ï ¼¼Æ÷ÁÖ¿¡¼­ ´Ù¾çÇÑ ¸¶ÀÌÅ©·Î RNAÀÇ Á¾¾ç ¾ïÁ¦ È¿°ú¸¦ Á¶»çÇÏ´Â ¿¬±¸°¡ Áõ°¡Çϸ鼭 ¸¶ÀÌÅ©·Î RNA ¿¬±¸ Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ miRNA ±â¹Ý Ä¡·áÁ¦´Â ´Ù¾çÇÑ Áúº´ Ä¡·á¿¡¼­ ³ôÀº ÀáÀç·ÂÀ» º¸¿©ÁÖ¸ç Áö¼ÓÀûÀ¸·Î ¹ßÀüÇϰí ÀÖÀ¸¸ç, miRNA ±â¹Ý Ä¡·áÁ¦¸¦ Ç¥Àû ¼¼Æ÷¿¡ Á¤È®ÇÏ°Ô Àü´ÞÇÏ´Â °ÍÀº ÀÓ»ó Àû¿ëÀ» À§ÇÑ Å« °úÁ¦·Î ³²¾ÆÀÖ½À´Ï´Ù. ±×·¯³ª ÃÖ±Ù ³ª³ëÀÔÀÚ ±â¹Ý Àü´Þ ½Ã½ºÅÛ°ú °°Àº È¿À²ÀûÀÎ Àü´Þ ½Ã½ºÅÛÀÇ µµÀÔÀÌ ÀÌ ¹®Á¦¸¦ ±Øº¹ÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©·Î RNA ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ¸¶ÀÌÅ©·Î RNA(miRNA) ½ÃÀå : ÁÖ¿ä ¿ä¾à

Á¦3Àå ¸¶ÀÌÅ©·Î RNA(miRNA) ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§

Á¦4Àå Á¦Ç°°ú ¼­ºñ½º ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¾ÖÇø®ÄÉÀÌ¼Ç ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå Áö¿ª ºñÁî´Ï½º ºÐ¼®

Á¦8Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

MicroRNA Market Growth & Trends:

The global microRNA market size is expected to reach USD 3.64 billion by 2030, registering a CAGR of 12.87% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is propelled by substantial investments in research and development initiatives for the development of novel diagnostic tests and therapeutics, coupled with the successful integration of microRNAs in clinical trials. The biopharmaceutical sector plays a significant role in the current biotechnology industry. The expenditure on R&D has significantly increased in the biotechnology industry. Several biopharmaceutical companies are investing in the development of RNA-based therapeutics (miRNAs & siRNAs). Some of the major players are Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics.

The substantial investments coupled with increased government funding in miRNA R&D initiatives for the development of new diagnostic tests & therapeutics are anticipated to boost the market growth. Several new players have arrived in the market with innovative approaches for the development of targeted therapeutics and identifying drug targets. For instance, in an article published in Elsevier in April 2022, a team of researchers provided a summary of current large-cohort studies that show the clinical value of circulating miRNAs for the early diagnosis of disease.

The rising number of studies investigating the tumor-suppressive effects of various microRNAs, particularly in cancer cell lines like thoracic cancer, is driving an increased demand for microRNA research tools. Additionally, miRNA-based therapeutics have demonstrated high potential in the treatment of various diseases and are continuously evolving. Accurate delivery of miRNA-based therapeutic agents to the targeted cells remains a major challenge for clinical applications. However, the recent introduction of efficient delivery systems, such as nanoparticle-based delivery systems, is anticipated to help overcome this challenge.

MicroRNA Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. MicroRNA (miRNA) Market: Executive Summary

Chapter 3. MicroRNA (miRNA) Market Variables, Trends, & Scope

Chapter 4. Products & Services Estimates & Trend Analysis

Chapter 5. Application Estimates & Trend Analysis

Chapter 6. End-use Estimates & Trend Analysis

Chapter 7. Regional Business Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â